Cargando…

Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma

The purpose of this study was to determine the profile of bioactive sphingolipids in xenograft mouse tissues of head and neck squamous cell carcinoma. We utilized UHPLC-MS/MS to determine the profile of full set of ceramides, sphingosine, and sphingosine 1-phosphate in this xenograft mouse model. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Aiping, Liu, Xiang, Bielawski, Jacek, Hannun, Yusuf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474618/ https://www.ncbi.nlm.nih.gov/pubmed/31002723 http://dx.doi.org/10.1371/journal.pone.0215770

Ejemplares similares

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells
por: Apraiz, Aintzane, et al.
Publicado: (2011)

Enhanced killing of SCC17B human head and neck squamous cell carcinoma cells after photodynamic therapy plus fenretinide via the de novo sphingolipid biosynthesis pathway and apoptosis
por: BOPPANA, NITHIN B., et al.
Publicado: (2015)

Stress-Induced Sphingolipid Signaling: Role of Type-2 Neutral Sphingomyelinase in Murine Cell Apoptosis and Proliferation
por: Devillard, Raphael, et al.
Publicado: (2010)

Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
por: KjellÃ©n, E., et al.
Publicado: (1989)

Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
por: Zakelj, Martina Niksic, et al.
Publicado: (2019)

The protein kinase Sch9 is a key regulator of sphingolipid metabolism in Saccharomyces cerevisiae
por: Swinnen, Erwin, et al.
Publicado: (2014)

Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid
por: Velazquez, Fabiola N., et al.
Publicado: (2020)

An Antioxidant, Probucol, Induces Anti‐angiogenesis and Apoptosis in Athymic Nude Mouse Xenografted Human Head and Neck Squamous Carcinoma Cells
por: Nishimura, Goshi, et al.
Publicado: (1999)

Molecular profiling of head and neck squamous cell carcinoma
por: Feldman, Rebecca, et al.
Publicado: (2015)

Coordination of Rapid Sphingolipid Responses to Heat Stress in Yeast
por: Chen, Po-Wei, et al.
Publicado: (2013)

A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells
por: Nishimura, Goshi, et al.
Publicado: (1999)

Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
por: Huizing, Fokko J., et al.
Publicado: (2018)

Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2020)

Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib
por: Hu, Fangling, et al.
Publicado: (2021)

Coordination of the dynamics of yeast sphingolipid metabolism during the diauxic shift
por: Alvarez-Vasquez, Fernando, et al.
Publicado: (2007)

Profiles of immune cell infiltration in head and neck squamous carcinoma
por: Liang, Bin, et al.
Publicado: (2020)

Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma
por: Lei, Zhen-ge, et al.
Publicado: (2016)

Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
por: Stanton, P., et al.
Publicado: (1994)

Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
por: Harms, Julia K., et al.
Publicado: (2019)

Xenograft models of head and neck cancers
por: Sano, Daisuke, et al.
Publicado: (2009)

Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model
por: Selvi, Ruthrotha B., et al.
Publicado: (2015)

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
por: Lemaire, F, et al.
Publicado: (2003)

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma
por: Lindgren, Gustaf, et al.
Publicado: (2014)

An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma
por: Carper, Miranda B., et al.
Publicado: (2019)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Editorial: Bioactive sphingolipids in health and disease
por: Aslan, Mutay, et al.
Publicado: (2022)

Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
por: Wijffels, K I E M, et al.
Publicado: (2000)

The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts
por: Hennessey, Patrick T., et al.
Publicado: (2011)

Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model
por: Chen, Chi-Yuan, et al.
Publicado: (2009)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma
por: Baker, Lauren C. J., et al.
Publicado: (2018)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts
por: Yao, Wenhao, et al.
Publicado: (2021)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
por: Li, Feng, et al.
Publicado: (2015)

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
por: Gerretsen, M., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_abpsprh0n9nkimdpik6pglhim0